← Leaderboards
Emaad M Abdel-Rahman
University Of Virginia Charlottesville
$97,066
Attributed
$97,066
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$97,066 · 1
By mechanism
M01$97,066 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Johannes D Veldhuis$25,455,020
- Alan D. Rogol$2,440,436
- Eugene J Barrett$22,317,830
- Mary L Vance$1,068,571
- Michael O Thorner$7,721,062
Others in their field
Top investigators on “Cardiovascular Disorder Chemotherapy”
- James F Toole · Wake Forest University Health Sciences$17,951,480
- Christopher M O'Connor · Duke University$16,943,599
- Leslie L Robison · University Of Minnesota Twin Cities$16,102,450
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$14,553,633
- Dan M Roden · Vanderbilt University Medical Center$11,317,563
- Andrew G. Bostom · Rhode Island Hospital (Providence, Ri)$10,300,000
Research focus
Cardiovascular Disorder ChemotherapyClinical ResearchDrug Screening /EvaluationHormone InhibitorHuman SubjectHuman Therapy EvaluationHypervolemiaHyponatremiaOral AdministrationVasopressins
Grant awards (4)
ORAL YM087 (CI-1025) TRIAL IN PATIENTS W EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA$48,533
M01 · FY2002 · RR
ORAL YM087 (CI-1025) TRIAL IN PATIENTS W EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA$48,533
M01 · FY2001 · RR
ORAL YM087 (CI-1025) TRIAL IN PATIENTS W EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA$0
M01 · FY2000 · RR
ORAL YM087 (CI-1025) TRIAL IN PATIENTS W EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA$0
M01 · FY2000 · RR